Zhang Mei, Zhang Yun, Zhang Wei, Zhao Yu-xia, Gao Yue-hua, Zhang Yuan-yuan
Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China.
Zhonghua Yi Xue Za Zhi. 2004 Aug 2;84(15):1252-6.
To establish the diagnostic criteria of intima-media thickening (IMT) of the carotid artery, femoral artery and thoracic aorta in normal subjects and evaluate the effects of drugs on IMT in patients with atherosclerosis with high-frequency ultrasound imaging.
259 normal subjects and 102 patients with atherosclerosis (AS) were studied. 134 normal subjects were examined by transesophegeal echocardiography. 102 patients with AS were randomly divided into 4 groups:simvastatin group, probucol group, captopril group, and placebo group. The values of IMT, including IMT of the normal segment (IMT(A)) and the maximal IMT of each artery (IMT(B)) of the carotid and femoral arteries, and thoracic aorta, the mean maximal IMT of the 4 arteries (IMT(C)), and the single maximal IMT among the 4 arteries (IMT(D)) were measured. The examinations were repeated in 3 years after treatments.
In carotid, and femoral arteries and thoracic aorta, IMT increased with aging. The IMT values of the carotid and femoral arteries and thoracic aorta were 0.63 mm +/- 0.15 mm, 0.68 mm +/- 0.21 mm, 1.02 mm +/- 0.22 mm respectively with the upper limits of 0.93 mm, 1.10 mm, and 1.46 mm respectively. IMT(A) increased 0.023 mm per year. The progression value of IMT(D) in all therapeutic groups were significantly lower than that of the control group (all P < 0.05).
It is suggested that the IMT > 0.93 mm, > 1.10 mm, and > 1.46 mm is be defined as indicators of IMT in carotid and femoral arteries and thoracic aorta respectively. Drug therapy can decrease the progression of atherosclerosis but has no effects on the IMT in normal segment of arteries. High frequency ultrasound technique is reliable in monitoring the progression or regression of atherosclerosis in peripheral arteries.
建立正常人群颈动脉、股动脉及胸主动脉内膜中层厚度(IMT)的诊断标准,并通过高频超声成像评估药物对动脉粥样硬化患者IMT的影响。
研究了259名正常受试者和102名动脉粥样硬化(AS)患者。134名正常受试者接受了经食管超声心动图检查。102名AS患者被随机分为4组:辛伐他汀组、普罗布考组、卡托普利组和安慰剂组。测量IMT值,包括颈动脉和股动脉正常节段的IMT(IMT(A))、各动脉的最大IMT(IMT(B))、胸主动脉的IMT、4条动脉的平均最大IMT(IMT(C))以及4条动脉中的单一最大IMT(IMT(D))。治疗3年后重复检查。
在颈动脉、股动脉和胸主动脉中,IMT随年龄增长而增加。颈动脉、股动脉和胸主动脉的IMT值分别为0.63 mm±0.15 mm、0.68 mm±0.21 mm、1.02 mm±0.22 mm,上限分别为0.93 mm、1.10 mm和1.46 mm。IMT(A)每年增加0.023 mm。所有治疗组的IMT(D)进展值均显著低于对照组(均P<0.05)。
建议将IMT>0.93 mm、>1.10 mm和>1.46 mm分别定义为颈动脉、股动脉和胸主动脉IMT的指标。药物治疗可减缓动脉粥样硬化的进展,但对动脉正常节段的IMT无影响。高频超声技术在监测外周动脉粥样硬化的进展或消退方面是可靠的。